Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

The Pelican IMPACT National Development Programme has successfully completed

 

The Pelican IMPACT (Improving Management for Patients with Advanced Colorectal Tumours) programme was a series of workshops focused on advanced and secondary colorectal cancer with four main topics: colorectal cancers which have spread to the liver, lung, peritoneum, or into the bladder and other pelvic organs.

The programme was delivered at scale, with workshops running across the UK reaching hundreds of practising clinicians. The programme was created by Mr Brendan Moran and Sarah Crane, CEO until April 2019 of Pelican Cancer Foundation, in conjunction with the Association of Coloproctology of Great Britain and Ireland (ACPGBI).

Thanks to the charitable funding that we received, the programme was free to attend for 7 core members of each colorectal team and over 1,400 cancer specialists were involved in this hugely important educational programme.

The main objective of Pelican IMPACT was:

‘To improve outcomes through enhancing early, and timely, access for patients with advanced and secondary colorectal cancer to specialist advice and services, utilising local and regional expertise wherever possible with an individualized patient centred care’.

This can be summarized as the right treatment, at the right time, in the right place, for each individual patient with colorectal cancer. It also places an emphasis on treatment being local where possible, but central where necessary.

With clinical leadership from eminent experts in the field, the workshops were led by the recent Presidents of the ACPGBI Professor Jim Hill (2017-18), Mr Brendan Moran (2018-19) and Miss Nicola Fearnhead (2019-20).

The programme had exceptional reach and wide participation from clinical teams across the UK. The workshops were delivered by a multidisciplinary faculty of 231 cancer specialists. With their support, we delivered 13 one-day workshops across England, Scotland, Wales, and Ireland to 1,187 clinicians, from 184 colorectal multidisciplinary teams (MDT’s), between January 2018 – January 2020.

The workshop approach was highly interactive, using real-life, anonymised patient cases, discussion and participant surveys to test current practice. There was strong input from palliative care specialists and a focus on integrating palliative care as “parallel” supportive care, and not just as end of life care.

The programme was principally funded by a grant of £161,000 by The Lady Yuen Peng McNeice Charitable Foundation and a grant of £50,000 from the ACPGBI. Pelican secured a further £36,670 in miscellaneous grants to support the programme. The charitable donations that we receive from donors (which includes, but is not limited to, individuals, Trust & Foundations, corporates, and industry) are central to funding the work that we carry out with cancer specialists.

Developing and delivering a programme of this scale was a huge achievement for Pelican. One of the comments made most often by participants was the strength of the face-to-face interaction, opportunities to meet local and regional experts and being able to explore pathways for their complex patients together.

Most importantly, feedback from the clinical teams participating was overwhelmingly positive and those who took part fed back the powerful message that Pelican IMPACT would improve outcomes and improve the care for people with advanced and recurrent cancer. ‘Superb day, really helpful to show how evidence is informing practice, how new innovations are being integrated into existing care pathways’ – Delegate attending South of England workshop.

From the verbal and written feedback given, we are in no doubt that this will improve the management for patients with advanced colorectal tumours, supporting doctors and nurses to improve length of life and quality of life, recognising that advanced or metastatic colorectal cancer may be amenable to cure, and if not, can be treated to improve a patient’s quality of life.

 

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy